---
title: "MHLW.SG (MHLW.SG) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MHLW.SG/news.md"
symbol: "MHLW.SG"
name: "MHLW.SG"
parent: "https://longbridge.com/en/quote/MHLW.SG.md"
datetime: "2026-03-09T18:26:55.974Z"
locales:
  - [en](https://longbridge.com/en/quote/MHLW.SG/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MHLW.SG/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MHLW.SG/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/MHLW.SG/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/MHLW.SG/news.md)


# MHLW.SG (MHLW.SG) — Related News

### [Ardelyx Says Japan Approves Tenapanor For Hyperphosphatemia](https://longbridge.com/en/news/98525474.md)
*2023-09-25T15:45:00.000Z*
> Biopharmaceutical company Ardelyx, Inc. (ARDX) announced Monday that its collaboration partner in Japan, Kyowa Kirin Co.

### [GSK Plc: MHLW In Japan To Review Supplementary New Drug Application For Nucala](https://longbridge.com/en/news/96765423.md)
*2023-09-01T11:59:45.000Z*
> GSK plc (GSK, GSK.L) announced the Japanese Ministry of Health, Labour and Welfare has accepted for review a supplementa

### [Astellas Submits NDA For Zolbetuximab In Japan For Advanced Gastric, Gastroesophageal Cancers](https://longbridge.com/en/news/89823675.md)
*2023-06-09T07:36:20.000Z*
> Astellas Pharma Inc. (ALPMY) announced Friday the submission of a New Drug Application or NDA to Japan's Ministry of Hea

### [Bayer : submits aflibercept 8 mg for marketing authorization in Japan](https://longbridge.com/en/news/81206864.md)
*2023-03-01T10:41:29.000Z*
> (marketscreener.com) Berlin, March 1, 2023 - Bayer has submitted an application to the Japanese Ministry of Health, Labo

### [Japan Ministry of Health, Labor and Welfare Approves Manufacturing and Marketing of Adtralza® (tralokinumab) in Japan for Adults with Atopic Dermatitis](https://longbridge.com/en/news/76252977.md)
*2022-12-23T10:31:30.000Z*
> LEO Pharma A/S, a global leader in medical dermatology, announced today that the Japan Ministry of Health, Labor and Wel

### [Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema](https://longbridge.com/en/news/74689485.md)
*2022-11-30T12:05:50.000Z*
> Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema.